Search Results - Hochster, H.S

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cancer (mBC)

    Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cancer (mBC... by Wainberg, Z.A, George, B, Goldman, J.W, Hochster, H.S, Kelly, K, Ko, A, O'Dwyer, P.J, Trunova, N, Waterhouse, D, Soliman, H.H

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)

    Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) by Bendell, J, Eckhardt, G.S, Hochster, H.S, Morris, V.K, Strickler, J, Kapoun, A.M, Wang, M, Xu, L, McGuire, K, Dupont, J, Faoro, L, Munster, P

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Phase I Trial of Oral Ridaforolimus (AP23573; MK-8669) in Combination with Bevacizumab for Patients with Advanced Cancers

    A Phase I Trial of Oral Ridaforolimus (AP23573; MK-8669) in Combination with Bevacizumab for Patients with Advanced Cancers by Nemunaitis, J, Hochster, H.S, Lustgarten, S, Rhodes, R, Ebbinghaus, S, Turner, C.D, Dodion, P.F, Mita, M.M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    313 - Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cancer (mBC)

    313 - Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cance... by Wainberg, Z.A., George, B., Goldman, J.W., Hochster, H.S., Kelly, K., Ko, A., O'Dwyer, P.J., Trunova, N., Waterhouse, D., Soliman, H.H.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    1256 Phase I trial of oral Deforolimus in combination with Bevacizumab in patients with advanced solid tumours

    1256 Phase I trial of oral Deforolimus in combination with Bevacizumab in patients with advanced solid tumours by Nemunaitis, J, Hochster, H.S, Lustgarten, S, Turner, C.D, Haluska, F, Mita, M.M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    68 - Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)

    68 - Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) by Bendell, J., Eckhardt, G.S., Hochster, H.S., Morris, V.K., Strickler, J., Kapoun, A.M., Wang, M., Xu, L., McGuire, K., Dupont, J., Faoro, L., Munster, P.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Eyelash trichomegaly secondary to panitumumab therapy

    Eyelash trichomegaly secondary to panitumumab therapy by Morris, L G T, Hochster, H S, Delacure, M D

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: